HRH1 and colitis: While antagonists at the H1R are without clinical relevance in the treatment of IBD or in animal models, blockade of histamine production or H4R function is beneficial in specific colitis models, such as dextran sodium sulfate (DSS)-induced colitis in mice (14–18).